New - European Medical Journal

This site is intended for healthcare professionals

Continue

News

Microscope used in respiratory infection research for Mycobacterium avium complex lung disease
Respiratory
18 May 2026

ATS 2026: Phase IIIb Trial Advances MAC Lung Disease Care

A Phase IIIb trial is evaluating inhaled amikacin for newly diagnosed Mycobacterium avium complex lung disease.
Dermatologist discussing medical dermatology updates with a patient during a skin consultation.
Dermatology
17 May 2026

SCALE 2026: Dermatology Pearls for Clinical Practice

SCALE 2026 highlighted medical dermatology updates spanning lasers, rosacea, acne, skin aging, and photoprotection.
Physician discussing endometriosis ovarian cancer risk with a patient during a gynecology consultation.
Oncology
17 May 2026

Endometriosis Ovarian Cancer Risk Needs Context

Endometriosis is linked to ovarian cancer risk, but absolute lifetime risk remains low for most patients.
Older adult receiving neurological care after traumatic brain injury and levetiracetam seizure prophylaxis.
Neurology
17 May 2026

Can Seizures Be Prevented After Brain Injury?

Levetiracetam appeared well tolerated after severe traumatic brain injury in octogenarians. Read more.
Pulmonologist reviewing lung imaging for idiopathic pulmonary fibrosis and inhaled treprostinil research.
Respiratory
17 May 2026

ATS 2026: TETON-1 Inhaled Treprostinil Slows IPF Decline

Inhaled treprostinil slowed lung function decline in TETON-1, a Phase III trial in idiopathic pulmonary fibrosis.
Healthcare professional discussing GLP-1 weight loss and aesthetic treatment concerns with a patient.
Dermatology
16 May 2026

SCALE 2026: GLP-1 Weight Loss Intensifies Aesthetic Care

GLP-1 weight loss may intensify aesthetic concerns linked to skin laxity, muscle tone, and body contouring.
Older adult discussing pulmonary tuberculosis outcomes and comorbidity risk with a healthcare professional.
Microbiology & Infectious Diseases
16 May 2026

Pulmonary Tuberculosis Outcomes Worsen with Comorbidities

Pulmonary tuberculosis outcomes worsened in older patients with diabetes, kidney disease, malignancy, or multimorbidity.
Doctor discussing gabapentinoids and asthma exacerbation risk with a patient with chronic pain
Respiratory
16 May 2026

Gabapentinoids Linked to Higher Asthma Risk

Gabapentinoids may increase asthma exacerbation risk in adults treated for chronic or neuropathic pain.
We’ve noticed you’re accessing
from North/South America.